Related Experiment Video
Updated: Jan 13, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Intersecting Endocrine Pathways in Cardiomyopathy: The Role of Metabolic Burden in Structural Heart Disease
Ovidiu Țica1,2, Mircea Ioan Șandor3, Anca Huniadi3
1Department of Morphological Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.
Insights
Non-insulin-treated diabetes and hypothyroidism significantly increase the risk of dilated cardiomyopathy (DCM). A metabolic burden score combining these factors aids in stratifying DCM and readmission risk.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Syndrome
Background:
- Dilated cardiomyopathy (DCM) is a primary cause of heart failure morbidity and mortality.
- The combined impact of type 2 diabetes mellitus (T2DM), obesity, and thyroid dysfunction on DCM is not well understood.
- These conditions are individually linked to cardiovascular disease.
Purpose of the Study:
- To assess the independent and combined associations of diabetes, thyroid dysfunction, and obesity with DCM prevalence.
- To evaluate the impact of these metabolic factors on 30-day hospital readmission rates.
- To examine the utility of a composite Metabolic Burden Score for risk stratification.
Main Methods:
- Retrospective analysis of 1079 adult patients' electronic health records.
- Multivariable logistic regression with ridge regularization to identify DCM predictors.
- Stratification of endocrine phenotypes and development of a 3-point Metabolic Burden Score.
Main Results:
- DCM prevalence was 46%; non-insulin-treated diabetes (OR 6.93) and hypothyroidism (OR 1.78) were independent predictors.
- Obesity contributed to DCM risk within the Metabolic Burden Score.
- DCM prevalence increased with the score, reaching 50% in the high-risk group; moderate-risk patients had the highest readmission rate (42.8%).
Conclusions:
- Non-insulin-treated diabetes and hypothyroidism are significant metabolic drivers of DCM.
- A composite Metabolic Burden Score effectively stratifies risk for DCM and early hospital readmission.
- Integrated endocrine-cardiac screening can improve early detection and prevention of structural heart disease.
Abstract:
Background: Dilated cardiomyopathy (DCM) is a major contributor to heart failure-related morbidity and mortality. While type 2 diabetes mellitus (T2DM), obesity, and thyroid dysfunction are individually linked to cardiovascular disease, their combined effects on DCM remain poorly understood. Objective: To evaluate the independent and synergistic associations of diabetes (stratified by treatment), thyroid dysfunction, and obesity with the prevalence of DCM and 30-day hospital readmission. We further examined the utility of a composite Metabolic Burden Score for risk stratification. Methods: In this retrospective cohort study, electronic health record data from 1079 adult patients at a tertiary care center were analyzed. Multivariable logistic regression, including ridge regularization, was used to identify predictors of DCM. Endocrine phenotypes were stratified by diabetes and thyroid status. A Metabolic Burden Score (range: 0-3) based on diabetes, obesity, and thyroid dysfunction was developed and correlated with clinical outcomes. Results: DCM was diagnosed in 46% of the cohort. Non-insulin-treated diabetes (OR: 6.93; 95% CI: 3.78-12.73), hypothyroidism (OR: 1.78; 95% CI: 1.02-3.11), and male sex (OR: 2.33; 95% CI: 1.36-4.00) were independently associated with increased DCM risk. Obesity was not independently predictive but contributed to DCM prevalence when assessed within the Metabolic Burden Score. DCM prevalence increased across burden strata, reaching 50% in the high-risk group. Notably, the moderate-risk group had the highest 30-day readmission rate (42.8%). Conclusions: Non-insulin-treated diabetes and hypothyroidism are key metabolic drivers of DCM. A simple composite burden score offers a clinically useful tool for stratifying risk of DCM and early readmission. These findings support integrated endocrine-cardiac screening strategies to improve early identification and prevention of structural heart disease.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Pathophysiology of Cardiac Performance

